[{"NetIncomeLoss_3_FY_USD":-3054441.0,"AssetsCurrent_0_FY_USD":1247200.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_FY_USD":2699715.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_3_FY_USD":911.446,"CurrentFederalTaxExpenseBenefit_3_FY_USD":0.0,"StockIssuedDuringPeriodValueNewIssues_3_FY_USD":25000.0,"NetCashProvidedByUsedInInvestingActivities_3_FY_USD":-143750000.0,"CommitmentsAndContingencies_0_FY_USD":null,"GeneralAndAdministrativeExpense_3_FY_USD":3061452.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"ProceedsFromRelatedPartyDebt_3_FY_USD":80000.0,"Liabilities_0_FY_USD":2798715.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":908111.0,"SharesIssuedPricePerShare_0_FY_USD":18.0,"PaymentsOfStockIssuanceCosts_3_FY_USD":391063.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_3_FY_USD":-270013.0,"StockIssuedDuringPeriodValueOther_3_FY_USD":140359937.0,"NetCashProvidedByUsedInFinancingActivities_3_FY_USD":145358937.0,"ProceedsFromIssuanceOfPrivatePlacement_3_FY_USD":4875000.0,"AssetsHeldInTrustNoncurrent_0_FY_USD":143757011.0,"EffectiveIncomeTaxRateContinuingOperations_3_FY_pure":0.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_3_FY_USD":908111.0,"BusinessAcquisitionPercentageOfVotingInterestsAcquired_0_FY_pure":0.5,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_FY_USD":2699715.0,"FederalDepositInsuranceCorporationPremiumExpense_3_FY_USD":250000.0,"CommonStockValue_0_FY_USD":114.0,"IncomeTaxExpenseBenefit_3_FY_USD":0.0,"BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0_FY_USD":3390063.0,"RepaymentsOfRelatedPartyDebt_3_FY_USD":80000.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":28198.0,"CurrentStateAndLocalTaxExpenseBenefit_3_FY_USD":0.0,"Assets_0_FY_USD":145004211.0,"PreferredStockSharesIssued_0_FY_shares":0.0,"AdditionalPaidInCapital_0_FY_USD":8053974.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_3_FY_USD":10000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_FY_shares":0.0,"BusinessAcquisitionSharePrice_0_FY_USD":10.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_FY_pure":0.21,"ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_0_FY_USD":9.2,"NetCashProvidedByUsedInOperatingActivities_3_FY_USD":-700826.0,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_3_FY_pure":-0.298,"OperatingLossCarryforwards_0_FY_USD":94497.0,"TangibleAssetImpairmentCharges_3_FY_USD":5000001.0,"DeferredFederalIncomeTaxExpenseBenefit_3_FY_USD":-641453.0,"DeferredTaxAssetsGross_0_FY_USD":911445.0,"PrepaidExpenseCurrent_0_FY_USD":339089.0,"MarketableSecurities_0_FY_USD":143757011.0,"StockholdersEquity_0_FY_USD":5000006.0,"ProceedsFromOtherEquity_3_FY_USD":140875000.0,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_3_FY_pure":0.088,"DeferredTaxAssetsValuationAllowance_0_FY_USD":911445.0,"BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_0_FY_pure":0.6,"PreferredStockSharesAuthorized_0_FY_shares":5000000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":145004211.0,"PreferredStockValue_0_FY_USD":0.0,"InvestmentIncomeInterest_3_FY_USD":7011.0,"OperatingIncomeLoss_3_FY_USD":-3061452.0,"RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0_FY_USD":137205490.0,"DeferredTaxAssetsNet_0_FY_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.0001,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-3054441.0,"IncreaseDecreaseInPrepaidExpense_3_FY_USD":339089.0,"Ticker":"NUVB","CIK":"1811063","name":"NUVATION BIO INC.","OfficialName":"Nuvation Bio Inc. Class A Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"1238973430.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210311"}]